Therapeutic considerations for stroke patients with antiphospholipid antibodies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 1561673.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A variety of therapeutic regimens including corticosteroids, immunosuppressants, antiplatelet agents, and anticoagulants have been prescribed to stroke patients with antiphospholipid antibodies. Although some of these medications may be useful in reducing the risk of recurrent thromboembolic events and deserve further investigation, studies published to date do not establish the effectiveness of any specific treatment. We conclude that a prospective study should be undertaken to assess the management of patients with antiphospholipid antibodies.
Medical subject headings
- Antibodies
- Cerebrovascular Disorders
- Phospholipids